socalTECH

APRIL 17, 2013

Monrovia, California-based biotherapeutics technology developer Xencor said Tuesday that it has licensed its Xtend technology to an Australian firm. Xencor and CSL Limited said they are in a technology license agreement, which will provide CSL access ot its technology, for use with CSL''s monoclonal antibodies.

Technology 147

Technology Monrovia Sales Product 147

socalTECH

DECEMBER 15, 2010

Monrovia-baesd Tanner EDA , the developer of mixed signal electronic design automation software, said today that it has expanded its presence in the Chinese market, and has signed up a new sales and support partner. Tanner said that it has appointed NewPlus Systems and Technologies Ltd.

Sales 150

Sales Monrovia Design Software 150

socalTECH

SEPTEMBER 16, 2015

Thousand Oaks-based Amgen , and Monrovia, California-based Xencor said this morning they are in a strategic collaboration worth as much as $1.7 billion to Xencor, to develop and commercialize cancer immunotherapy and inflammation drugs. The two said that Amgen will pay Xencor $45M upfront, with the potential of up to $1.7

Thousand Oaks 100

Thousand Oaks Monrovia Platform Sales 100

socalTECH

JULY 2, 2013

Monrovia-based Xencor announced today that it is in a technology license and option agreement with biotech giant Merck. Xencor is developing antibody technology which it has widely licensed to companies such as Amgen, Pfizer, Janssen R&D LLC, MorphoSys, Boehringer Ingelheim, CSL Ltd. and Human Genome Sciences.

Patents 138

Patents Monrovia Sales Technology 138

socalTECH

MAY 21, 2010

Monrovia-based Tanner EDA , a developer of analog and mixed-signal integrated circuit design software, said this week that it has expanded its efforts in Asia, and has signed up Advinno Technologies Pte. Ltd to represent the firm in Southeast Asia.

Monrovia 124

Monrovia Design Software Sales 124